Stephan Chalon

Stephan Chalon

UNVERIFIED PROFILE

Are you Stephan Chalon?   Register this Author

Register author
Stephan Chalon

Stephan Chalon

Publications by authors named "Stephan Chalon"

Are you Stephan Chalon?   Register this Author

19Publications

264Reads

10Profile Views

Effect of moxidectin on CYP3A4 activity as evaluated by oral midazolam pharmacokinetics in healthy subjects.

Clin Pharmacol Drug Dev 2014 Mar 22;3(2):151-7. Epub 2013 Oct 22.

College of Pharmacy, University of Iowa, Iowa City, IA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cpdd.81DOI Listing
March 2014

Evaluation of the pharmacokinetics and safety of bosutinib in patients with chronic hepatic impairment and matched healthy subjects.

Cancer Chemother Pharmacol 2013 Jan 30;71(1):123-32. Epub 2012 Sep 30.

Department of Clinical Pharmacology, Pfizer Inc, Collegeville, PA 19426, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00280-012-1987-7
Publisher Site
http://dx.doi.org/10.1007/s00280-012-1987-7DOI Listing
January 2013

A phase I ascending single-dose study of the safety, tolerability, and pharmacokinetics of bosutinib (SKI-606) in healthy adult subjects.

Cancer Chemother Pharmacol 2012 Jan 21;69(1):221-7. Epub 2011 Jun 21.

Department of Clinical Pharmacology, Pfizer Inc, 500 Arcola Road, Collegeville, PA 19426, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-011-1688-7DOI Listing
January 2012

Comparative effects of duloxetine and desipramine on sleep EEG in healthy subjects.

Psychopharmacology (Berl) 2005 Feb 28;177(4):357-65. Epub 2004 Jul 28.

Lilly Research Laboratories, Indianapolis, IN 46285, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00213-004-1961-0DOI Listing
February 2005

Duloxetine increases serotonin and norepinephrine availability in healthy subjects: a double-blind, controlled study.

Neuropsychopharmacology 2003 Sep 28;28(9):1685-93. Epub 2003 May 28.

Lilly Research Laboratories, Mont-Saint-Guibert, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/sj.npp.1300209DOI Listing
September 2003

Effect of hepatic impairment on the pharmacokinetics of atomoxetine and its metabolites.

Clin Pharmacol Ther 2003 Mar;73(3):178-91

Department of Clinical Pharmacology, Lilly Research Laboratories, Lilly Development Centre SA, Parc Scientifique de Louvain-La-Neuve, Rue Granbonpré 11, 1348 Mont-Saint-Guibert, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1067/mcp.2003.25DOI Listing
March 2003